Immunic is a biotechnology company developing oral drugs for multiple sclerosis and gastrointestinal diseases. It last closed at $6.99 on Nov 20, down 5.41% on the day. The next earnings report for IMUX is expected around Thu, Feb 25, 2027. For the quarter ended Sep 2026, IMUX reported EPS of -$0.99. Over its last 8 reports the stock moved an average of 6.9% the session after earnings.
AI Auto Pilots
Is IMUX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold IMUX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on IMUXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
IMUX · as of the Nov 20 close · updated each morning
Downtrend
The stock is 9% below its 20 day and 17% below its 50 day average. It is 66% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 39). The nearest support is the Pivot S1 at $6.79, and the nearest resistance the Pivot at $7.17.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityNormal, 8.3%/day
Key levels
$17.4352 week high+149.4%
$11.59200 day average+65.8%
$11.46100 day average+63.9%
$8.22Swing high (Oct 29)+17.6%
$8.2050 day average+17.3%
$7.6020 day average+8.7%
$7.38Pivot R1+5.6%
$7.17Pivot+2.6%
$6.99Last close
$6.79Pivot S1−2.9%
$6.35Swing low (Oct 14)−9.2%
$5.0652 week low−27.6%
Indicators
RSI (14)
38.64
Weak, oversold below 30
Neutral
MACD
-0.28
Above its signal line
Bullish
Stochastic
19.8
Near the bottom of its range
Oversold
ADX (14)
18.5
No clear trend
Williams %R
-98.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-144.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−9.8%
Change over 10 sessions
Bearish
ATR (14)
$0.58
Typical daily range, 8.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 25.4%/day
Key levels
$17.4352 week high+149.4%
$11.59200 day average+65.8%
$11.46100 day average+63.9%
$8.22Swing high (Oct 29)+17.6%
$8.2050 day average+17.3%
$7.6020 day average+8.7%
$7.38Pivot R1+5.6%
$7.17Pivot+2.6%
$6.99Last close
$6.79Pivot S1−2.9%
$6.35Swing low (Oct 14)−9.2%
$5.0652 week low−27.6%
Indicators
RSI (14)
34.29
Weak, oversold below 30
Neutral
MACD
-1.38
Below its signal line
Bearish
Stochastic
9.7
Near the bottom of its range
Oversold
ADX (14)
27.9
Trending down
Williams %R
-94.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-86.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−38.8%
Change over 10 sessions
Bearish
ATR (14)
$1.77
Typical daily range, 25.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for IMUX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how IMUX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow IMUX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for IMUXHow many large options trades hit IMUX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in IMUX in the last 90 days.
From SEC Form 4 filings by IMUX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IMUX is in one of them and how their past IMUX trades turned out.
Immunic is a biotechnology company that develops oral drugs for neurologic and gastrointestinal diseases. Its lead candidate, vidofludimus calcium, is in Phase 3 testing for relapsing multiple sclerosis, and its IMU-856 candidate is being developed for conditions such as celiac disease and inflammatory bowel disease. The company has no products approved for sale yet and has not generated revenue from product sales. It is headquartered in New York, with its main research operations in Germany.